TrackPaw Scientific
A platform aimed towards improving the current way of monitoring rodents used in preclinical research.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
* | N/A | Seed | |
| Total Funding | 000k | ||
| SEK | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | 1399 % | 131 % |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| % profit margin | (104 %) | (48 %) | (85 %) |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
TrackPaw Scientific is an innovative life science startup based in Lund, Sweden, operating from the Ideon Science Park. The company specializes in providing advanced digital monitoring solutions for laboratory animals used in preclinical drug development. TrackPaw's primary clients are research-based pharmaceutical and biotechnology companies that require precise and continuous monitoring of animal behavior and physiological parameters.
The core product offered by TrackPaw is a hardware and Software-as-a-Service (SaaS) platform. This platform includes sensors that continuously record animal behavior and weight, and a cloud-based solution that analyzes the collected data. The system operates 24/7, significantly reducing the need for manual intervention, which can be stressful for the animals and can introduce biases into the research data. By automating the monitoring process, TrackPaw enhances data quality, ensures animal welfare, and accelerates drug development timelines.
TrackPaw's business model revolves around selling its hardware sensors and offering subscription-based access to its cloud-based data analysis platform. This dual revenue stream allows the company to generate income from both the initial sale of the monitoring equipment and ongoing subscription fees for data analysis services. Additionally, the built-in alarm function of the system alerts researchers to any unforeseen activities in the animal cages, enabling quick interventions that can prevent data loss or the need for study repetition.
The company was founded by Liza Tchapanova Albrektson, who identified a global need for improved laboratory animal management systems during her tenure in preclinical drug development. With a strong background in biomedicine and extensive experience in immunobiology, neurodegenerative diseases, and oncology, Liza drives the commercial and strategic development of TrackPaw, ensuring that the product evolves in line with market needs.
Keywords: digital monitoring, laboratory animals, SaaS, hardware sensors, pharmaceutical research, biotech, data analysis, animal welfare, preclinical drug development, automated tracking.